Visualizing amyloidosis: the role of radionuclide imaging in systemic amyloidosis
Abstract
Abstract Hematologists have a significant role in the diagnosis and management of light-chain amyloidosis and are frequently involved in the diagnosis of transthyretin and other more rare types of amyloidosis. Recent advances in diagnostic techniques and therapies are dramatically improving patient prognosis. Radionuclide imaging methods are emerging as a highly specific and noninvasive way to diagnose, quantify, and monitor organ involvement representing a major advance in amyloidosis management.
Article Details
Authors (3)
Nirija Ranjit Anderson
1Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
Sharmila Dorbala
Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women’s Hospital, Boston, MA (D.M.L., B.N.W., J.H., S.C., R.B., S.D., M.F.D.).
Peter Mollee
10Department of Haematology, Princess Alexandra Hospital and University of Queensland, Brisbane, Australia